9SAF
Ternary PROTAC-mediated complex of BRD4-BD1/CRBN/DDB1 and JQ1-AcQ bifunctional degrader
This is a non-PDB format compatible entry.
Summary for 9SAF
| Entry DOI | 10.2210/pdb9saf/pdb |
| EMDB information | 54690 |
| Descriptor | DNA damage-binding protein 1, Protein cereblon, Bromodomain-containing protein 4, ... (6 entities in total) |
| Functional Keywords | cryo-em ddb1 (dna damage-binding protein 1) crbn (cereblon) brd4 (bromodomain containing 4) protein degradation cyclimid protacs, ligase |
| Biological source | Homo sapiens (human) More |
| Total number of polymer chains | 3 |
| Total formula weight | 159810.75 |
| Authors | Peter, D.,Fischer, G.,Arce Solano, S.,Kessler, D. (deposition date: 2025-08-07, release date: 2025-10-01, Last modification date: 2025-10-08) |
| Primary citation | Zhu, Q.,Fischer, G.,Cheng, S.S.,Payne, N.C.,Peter, D.,Mody, A.C.,Arce-Solano, S.,Shen, D.,Lin, Z.,Mazitschek, R.,Kessler, D.,Woo, C.M. Enzyme-Activated Sugar-Coated Bifunctional Degraders. J.Am.Chem.Soc., 147:34672-34680, 2025 Cited by PubMed Abstract: Targeted protein degradation with compounds like proteolysis targeting chimeras (PROTACs) directs disease-associated proteins to the E3 ligase ubiquitin-proteasome system for removal. However, commonly employed E3 ligases such as cereblon (CRBN) are broadly expressed. To metabolically gate PROTAC activity, we developed an enzymatic activation strategy by integrating an O-GlcNAc modification to the cyclimids, ligands derived from the natural motifs recognized by CRBN. These sugar-coated PROTACs (SCPs) were designed using structural analyses of representative cyclimid degraders complexed with CRBN and target protein BRD4. We found that glycosylation of the cyclimid reduced CRBN binding and complex formation with BRD4 until enzymatic removal of the O-GlcNAc moiety by O-GlcNAcase (OGA). The requirement for enzymatic activation is demonstrated by biochemical binding, cellular degradation, and cell viability assays in engineered and native cell lines. O-GlcNAc is thus an effective mechanism to gate targeted protein degradation modalities that motivates the development of similar strategies to enhance selectivity with other protein modifications. PubMed: 40937862DOI: 10.1021/jacs.5c09843 PDB entries with the same primary citation |
| Experimental method | ELECTRON MICROSCOPY (2.55 Å) |
Structure validation
Download full validation report
